Kolexia
Tilleul Patrick
Pharmacien
Hôpital Pitie Salpetriere
Paris, France
96 Activités
226 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs du sein Nécrose Anémie Sclérose en plaques Infections à Clostridium COVID-19 Douleur postopératoire Lésions hépatiques dues aux substances Sclérose

Industries

Roche
26 collaboration(s)
Dernière en 2023
Biogaran
7 collaboration(s)
Dernière en 2023
UCB
5 collaboration(s)
Dernière en 2021
Jazz Pharmaceuticals
4 collaboration(s)
Dernière en 2020

Dernières activités

Cost effectiveness of using trastuzumab biosimilars compared to trastuzumab original drugs to treat breast cancer in a hospital setting.
Breast (Edinburgh, Scotland)   11 octobre 2023
Qualification of low temperature vaporized hydrogen peroxide sterilization: Towards greater harmonization of practices?.
Annales pharmaceutiques francaises   12 novembre 2022
Therapeutic Treatment Plan Optimization during the COVID-19 Pandemic: A Comprehensive Physicochemical Compatibility Study of Intensive Care Units Selected Drugs.
Pharmaceutics   28 février 2022
Successful Targeting of an ATG7-RAF1 Gene Fusion in Anaplastic Pleomorphic Xanthoastrocytoma With Leptomeningeal Dissemination.
JCO precision oncology   01 février 2022
Antiretroviral drug reduction in highly experienced HIV-infected patients receiving a multidrug regimen: the ECOVIR study.
The Journal of antimicrobial chemotherapy   19 août 2020
Shortage of sedatives and neuromuscular blockers during COVID-19 pandemic: The result of an overstocking procedure in French hospitals?
Anaesthesia, critical care & pain medicine   30 juin 2020
Unmet needs in clinical nutrition in oncology: a multinational analysis of real-world evidence.
Therapeutic advances in medical oncology   14 février 2020
PND11 IMPACT OF A COMMUNITY PHARMACY-BASED INFORMATION PROTOCOL ON MULTIPLE SCLEROSIS PATIENTS' ADHERENCE TO THEIR ORAL TREATMENT WITH DIMETHYL FUMARATE: TECPHIE, A RANDOMIZED STUDY VS USUAL PRACTICE (INTERIM RESULTS)
ISPOR Europe 2019   01 novembre 2019
Physical and chemical stability of a generic etoposide formulation as an alternative to etoposide phosphate.
Journal of pharmaceutical and biomedical analysis   29 septembre 2019
ISO 9001 certification of a sterilization unit: Transition to the 2015 version.
Annales pharmaceutiques francaises   27 juin 2019